Vitamin D and Viral Hepatitis: The New Issue in Pathogenesis and Outcomes

Shahriar Najafizadeh-Sari, Mohammad Hossein Khosravi


Searching the term “vitamin D” in a database like PubMed results in about 80 000 articles and shows that the number of submitted articles has raised exponentially in recent years. This number about equals the results for “hepatitis B”, indicating that new roles for vitamin D in the body have been proven in recent years. Vitamin D is a vital substance that plays a lot of important roles in the body, e.g., it reduces mortality risk in the elderly,1 it displays anticancer properties,2 and has a regulatory role in calcium and bone homeostasis. Vitamin D is also an important immune modulator that plays important roles in infectious diseases such as viral hepatitis...

Full Text:



Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;(7):Cd007470. doi:10.1002/14651858.CD007470.pub2.

Byers T. Anticancer Vitamins du Jour—The ABCED’s So Far. Am J Epidemiol. 2010;172(1):1-3. doi:10.1093/aje/kwq112.

Tavakolpour S, Sali S, Gachkar L. Association of plasma levels of vitamin D with chronic hepatitis B infection. Hepat Mon. 2016;16(1):e35525. doi:10.5812/hepatmon.35525.

Hewison M. Vitamin D and innate and adaptive immunity. Vitam Horm. 2011;86:23-62. doi:10.1016/B978-0-12-386960-9.00002-2.

Wong GL, Chan HL, Chan HY, et al. Adverse effects of vitamin D deficiency on outcomes of patients with chronic hepatitis B. Clin Gastroenterol Hepatol. 2015;13(4):783-790.e781. doi:10.1016/j.cgh.2014.09.050.

Petta S, Camma C, Scazzone C, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51(4):1158-1167. doi:10.1002/hep.23489.

Kmush BL, Labrique A, Li W, et al. The association of cytokines and micronutrients with hepatitis E virus infection during pregnancy and the postpartum period in rural Bangladesh. Am J Trop Med Hyg. 2016;94(1):203-211. doi:10.4269/ajtmh.15-0238.

Busca A, Kumar A. Innate immune responses in hepatitis B virus (HBV) infection. Virol J. 2014;11:22. doi:10.1186/1743-422X-11-22.

Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 2010;58(4):258-266. doi:10.1016/j.patbio.2009.11.001.

Luong K, Nguyen LT. Theoretical basis of a beneficial role for vitamin D in viral hepatitis. World J Gastroenterol. 2012;18(38):5338- 5350. doi:10.3748/wjg.v18.i38.5338.

Thompson AJ, Locarnini SA. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol. 2007;85(6):435-445. doi:10.1038/sj.icb.7100100.

Katze MG, He Y, Gale M Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2(9):675-687. doi:10.1038/nri888.

Hosel M, Quasdorff M, Wiegmann K, et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology. 2009;50(6):1773-1782. doi:10.1002/hep.23226.

Wu J, Meng Z, Jiang M, et al. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology. 2010;129(3):363-374. doi:10.1111/j.1365-2567.2009.03179.x.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Creative Commons License
International Journal of Medical Reviews is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.